Fuse Medical, Inc. (FZMD)
USD 0.12
(0.0%)
USD 0.12
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 443.78 Thousand | 34.79 Thousand | -1.77 Million | 236.65 Thousand | -4739.00 | 2.47 Million |
| Net Income | 1.45 Million | 3.09 Million | -1.58 Million | -1.43 Million | -3.31 Million | 3.95 Million |
| Depreciation & Amortization | 131.57 Thousand | 137.4 Thousand | 67.63 Thousand | 104.14 Thousand | 107.07 Thousand | 49.68 Thousand |
| Deferred income taxes | - | - | -497.89 Thousand | 1.33 Million | 760.99 Thousand | -431.27 Thousand |
| Stock-based compensation | - | 22.85 Thousand | 257.91 Thousand | 553.18 Thousand | 627.67 Thousand | 834.92 Thousand |
| Change in working capital | -523.6 Thousand | -596.17 Thousand | 324.07 Thousand | -611.13 Thousand | 50.8 Thousand | 3.56 Million |
| Other non-cash items | 2.19 Million | -2.62 Million | -342.16 Thousand | 290.63 Thousand | 1.76 Million | -5.49 Million |
| Investing Cash Flow | - | - | - | -20.75 Thousand | -15.31 Thousand | -104.93 Thousand |
| Investments in PPE | -443.78 Thousand | - | - | -20.75 Thousand | -15.31 Thousand | -41.83 Thousand |
| Acquisitions | - | - | - | - | - | -63.09 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -353.47 Thousand | -440.13 Thousand | 1.14 Million | -127.74 Thousand | 275.05 Thousand | -2.33 Million |
| Debt repayment | -353.47 Thousand | -440.13 Thousand | -1.64 Million | -839.14 Thousand | -275.05 Thousand | -1.93 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 11 Thousand | - | - | - |
| Other Financing Activities | - | -440.13 Thousand | 2.78 Million | 711.4 Thousand | 550.1 Thousand | -2.33 Million |
| Accounts receivables | 603.19 Thousand | -1.88 Million | -64.07 Thousand | -1.98 Million | -1.62 Million | 917.68 Thousand |
| Accounts payables | -3.39 Million | 1.23 Million | 1.22 Million | 483.73 Thousand | 39.93 Thousand | -82.82 Thousand |
| Inventory | 227.58 Thousand | -1.47 Million | -1.16 Million | 1.6 Million | 1.12 Million | 1.88 Million |
| Other working capital | 2.03 Million | 1.52 Million | 331.61 Thousand | -713.92 Thousand | 508.33 Thousand | 846.73 Thousand |
| Cash at beginning of period | 147.85 Thousand | 553.19 Thousand | 1.18 Million | 1.09 Million | 844.31 Thousand | 804.71 Thousand |
| Cash at end of period | 238.16 Thousand | 147.85 Thousand | 553.19 Thousand | 1.18 Million | 1.09 Million | 844.31 Thousand |
| Capital Expenditure | -443.78 Thousand | - | - | -20.75 Thousand | -15.31 Thousand | -41.83 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 90.31 Thousand | -405.33 Thousand | -634.26 Thousand | 88.14 Thousand | 254.99 Thousand | 39.59 Thousand |
| Free Cash Flow | - | 34.79 Thousand | -1.77 Million | 215.89 Thousand | -20.05 Thousand | 2.43 Million |
| Breakdown | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.45 Million | 307.58 Thousand | -228.36 Thousand | 3.55 Million | 3.09 Million | -9376.00 |
| Depreciation & Amortization | 131.57 Thousand | 32.71 Thousand | 33.42 Thousand | -88.84 Thousand | 137.4 Thousand | 82.19 Thousand |
| Deferred income taxes | - | -4102.00 | - | - | - | 7278.00 |
| Stock-based compensation | - | 4102.00 | - | 1758.00 | 22.85 Thousand | 4148.00 |
| Change in working capital | -523.6 Thousand | -678.22 Thousand | 269.08 Thousand | -1.42 Million | -596.17 Thousand | 67.97 Thousand |
| Other non-cash items | 2.19 Million | 238.71 Thousand | 256.8 Thousand | -2.88 Million | -2.62 Million | 43.15 Thousand |
| Investing Cash Flow | - | - | - | 520.79 Thousand | - | -97.82 Thousand |
| Investments in PPE | - | 99.2 Thousand | - | 520.79 Thousand | - | -97.82 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -353.47 Thousand | 141.58 Thousand | -267.8 Thousand | -47.47 Thousand | -440.13 Thousand | -195.56 Thousand |
| Debt repayment | -353.47 Thousand | -141.58 Thousand | -267.8 Thousand | -47.47 Thousand | -440.13 Thousand | -200.06 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 283.17 Thousand | -267.8 Thousand | -47.47 Thousand | -440.13 Thousand | 4500.00 |
| Accounts receivables | 603.19 Thousand | -1.46 Million | 704.47 Thousand | -1.92 Million | -1.88 Million | 42.36 Thousand |
| Accounts payables | -3.39 Million | -313.23 Thousand | -1.14 Million | 877.95 Thousand | 1.23 Million | 40.56 Thousand |
| Inventory | 227.58 Thousand | 336.35 Thousand | 387.98 Thousand | -577.44 Thousand | -1.47 Million | -367.38 Thousand |
| Other working capital | 2.03 Million | 760.98 Thousand | 325.41 Thousand | 203.65 Thousand | 1.52 Million | 352.43 Thousand |
| Cash at beginning of period | 147.85 Thousand | 210.99 Thousand | 147.85 Thousand | 505.98 Thousand | 553.19 Thousand | 603.99 Thousand |
| Cash at end of period | 238.16 Thousand | 253.37 Thousand | 210.99 Thousand | 147.85 Thousand | 147.85 Thousand | 505.98 Thousand |
| Capital Expenditure | - | 99.2 Thousand | - | 520.79 Thousand | - | -97.82 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 90.31 Thousand | 42.38 Thousand | 63.14 Thousand | -358.13 Thousand | -405.33 Thousand | -98 Thousand |
| Free Cash Flow | 443.78 Thousand | -1.00 | 330.95 Thousand | -310.66 Thousand | 34.79 Thousand | 97.55 Thousand |
FIISO
1712
TLTFF
CE
XTG
VRTHF